Clinique Continuous Coverage SPF 15
Natural health product licensed in Canada
- Licence holder
- Clinique Laboratories, Dist.
- NPN or DIN-HM
- 02242283
- Status
- Inactive licence
- Licence date
- 24 October 2008
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Polydecene, (p)-hydroxybenzoate de butyle, cholestérol, Parahydroxybenzoate de méthyle, Hectorite de Distérdimonium, Stéarate de PEG-100, Mica, (p)-hydroxybenzoate de propyle, Dioxyde de titane, Silicate d'aluminium et de magnésium, Butylène glycol, Phényl triméthicone, Acide stéarique, Stéarate de glycéryle, Tromethamine, Talc, Algin, Citrate de triéthyle, Cellulose gum, Acide isostéarique, Microcrystalline cellulose, Eau, Dioxyde de fer, Bismuth Oxychloride
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | Not specified | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
SPF 15
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 02242283
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.